Average Co-Inventor Count = 4.66
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (53 from 3,224 patents)
2. Seattle Genetics, Inc. (4 from 132 patents)
3. Genetech, Inc. (3 from 98 patents)
4. Nerviano Medical Sciences S.r.l. (1 from 139 patents)
5. F. Hoffmann-La Roche Ag (168 patents)
6. Seagen Inc. (64 patents)
7. Spirogen Sarl (8 patents)
60 patents:
1. 12281165 - Anti-B7-H4 antibodies and immunoconjugates
2. 12134649 - Anti-B7-H4 antibodies and immunoconjugates
3. 11286302 - Anti-B7-H4 antibodies and immunoconjugates
4. 11230600 - Anti-B7-H4 antibodies and immunoconjugates
5. 10889651 - Anti-Ly6E antibodies and methods of use
6. 10196454 - Anti-PMEL17 antibodies and immunoconjugates
7. RE47223 - Compositions and methods for the diagnosis and treatment of tumor
8. 10150813 - Anti-B7-H4 antibodies and immunoconjugates
9. 10066022 - Anti-Ly6E antibodies and methods of use
10. 10059768 - Anti-B7-H4 antibodies and immunoconjugates
11. 10017577 - Antibodies and immunoconjugates
12. 9994643 - Compositions and methods for the diagnosis and treatment of tumor
13. 9926377 - Anti-GPC3 antibodies and immunoconjugates
14. 9815905 - Compositions and methods for the diagnosis and treatment of tumor
15. 9695240 - Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds